Raynaud's Syndrome Completed Phase 3 Trials for Fasudil (DB08162)

Also known as: Raynaud’s phenomenon / Raynaud's Phenomenon / Raynaud’s syndrome / Raynaud Syndrome / Raynaud / Raynaud's Disease / Raynaud phenomenon / Raynauds / Raynaud's syndrome NOS / Raynauds' phen / Raynaud Disease

IndicationStatusPhase
DBCOND0049133 (Raynaud's Syndrome)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00498615A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's PhenomenonTreatment